Skip to main navigation
Skip to search
Skip to main content
University of Kentucky Home
LOGIN & Help
Home
Research units
Researchers
Projects & Grants
Research Output
Facilities & Equipment
Honors & Awards
Activities
Search by expertise, name or affiliation
Cryptophycin anticancer drugs revisited.
Jürgen Rohr
Pharmaceutical Sciences
Markey Cancer Center / Cancer Research Priority Initiative
Translational Oncology Research Program
Research output
:
Contribution to journal
›
Comment/debate
18
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Cryptophycin anticancer drugs revisited.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Biochemistry, Genetics and Molecular Biology
Anabolism
100%
Anticancer
100%
Clinical Trial
50%
Enzyme
50%
Precursor
50%
Symbiont
50%
Genetic Code
50%
Immunology and Microbiology
Biosynthesis
100%
Symbiont
50%
Back
50%
Lichen
50%
Precursor
50%
Genetic Code
50%